Bone marrow-derived dendritic cells (BM-DCs) are generated from bone marrow (BM) cells cultured with granulocyte macrophage-colony stimulating factor (GM-CSF) for a week. In this study we investigated the effect of duration on the BM culture with GM-CSF. Within several months, the cells in the BM culture gradually expressed homogeneous levels of CD11c and major histocompatibility complex II on surface, and they became unable to stimulate allogeneic naïve T cells in mixed lymphocyte reaction (MLR). In addition, when the BM culture were sustained for 32 wk or longer, the BM cells acquired ability to suppress the proliferation of allogeneic T cells in MLR as well as the response of ovalbumin-specific OT-I transgenic T cells in antigen-dependent manner. We found that, except for programmed death-ligand 1, most cell surface molecules were expressed lower in the BM cells cultured with GM-CSF for the extended duration. These results indicate that BM cells in the extended culture with GM-CSF undergo 2 distinct steps of functional change; first, they lose the immunostimulatory capacity; and next, they gain the immunosuppressive ability.
DCs are efficiently generated from BM following in vitro culture with GM-CSF for a week, which has been a standard way to produce BM-derived DCs (BM-DCs) for various experiments (3, 7, 8) . Although culturing BM-DCs is a less cumbersome method to prepare DCs in quantity than isolating in situ DCs from animal organs and tissues, it still requires freshly isolated BM cells (BMCs) and laborious cell culture procedures. To provide better convenient tools for experimenting with DCs, there have been efforts to establish immortalized cell-lines that retain the characteristics and functions of BM-DCs (9, 10) . DC-like cell-lines, such as DC2.4, were generated from BM cells cultured with GM-CSF, immortalized with J2 retrovirus encoding viral myc and raf oncogenes, and selected for dendritic morphology (9) . Initially, DC2.4 cell-line was described to present antigens efficiently (9) and many researchers have used DC2.4 cell-line instead of BM-DCs for various experiments in vitro and in vivo (11) (12) (13) (14) (15) . A later study, however, revealed that DC2.4 cell-line could become poor in presenting antigens to the responding T cells (16) .
In this study, we continuously propagated BM cells with GM-CSF for extended periods, i.e., up to a year or longer, and evaluated their ability to stimulate T cells. In several months of culture with GM-CSF, BM cells expressed homogeneous levels of major histocompatibility complex (MHC) class II (MHC II) and CD11c on surface but were unable to induce the proliferation of allogeneic T cells in mixed lymphocyte reaction (MLR). Then, after further extension of the culture period, we also found that those cells in the BM culture became immunosuppressive to prevent the responses of both allogeneic T cells and ovalbumin (OVA)-specific OT-I transgenic T cells.
MATERIALS AND METHODS

Animals
Mice were maintained and bred in specific pathogen-free facilities of the Department of Laboratory Animal Resources at the Yonsei University College of Medicine. OT-1 transgenic (Tg) mice carrying anti-OVA T cell receptors (TCRs) and congenic CD45.1 (B6.SJLPtprc a Pepc b /BoyJ) C57BL/6 mouse were purchased from Jackson Laboratory (Bar Harbor, ME, USA) and bred in house. C57BL/6 and BALB/c mice were purchased from Jackson Laboratory and Orient Bio (Seongnam, Korea). Animal care and experiments were carried out according to the guidelines and protocols set by the Institutional Animal Care and Use Committee (IACUC) of the Yonsei University College of Medicine.
Cells, antibodies, and reagents
Cells were cultured in DMC7 medium (17) composed of DMEM containing L-glutamine, high glucose, and pyruvate (catalog number SH30243; HyClone, Logan, UT, USA) and 7% fetal calf serum (HyClone) supplemented with 1× solutions of non-essential amino acids (HyClone) and antibiotic-antimycotic (HyClone).
Following conjugated anti-mouse antibodies were purchased from BioLegend (San Diego, CA, USA): APC-Cy7-conjugated anti-I-A/I-E (anti-MHC II, clone: M5/114.15.2), and anti-CD45.2 (clone: 104); PE-conjugated anti-CD11c (clone: N418), anti-CD4 (clone: GK1.5), anti-CD8a (clone: 53-5.8), and anti-programmed death ligand 2 (PD-L2; clone: TY25); PerCPCy5.5-conjugated anti-CD11c (clone: N418), anti-CD8a (clone: 53-5.8), and anti-Vα2 (clone: B20.1); PE-Cy7-conjugated anti-TCR β chain (clone: H57-597), and anti-CD11b (clone: M1/70); BV421-conjugated anti-programmed death-ligand 1 (PD-L1; clone: 10F.9G2); Alexa Fluor 647-conjugated anti-IDO1 (clone: 2E2/IDO1); biotin-conjugated anti-CD19 (clone: 6D5), 
BM culture
Whole BM cell suspension was prepared from femurs and tibias of C57BL/6 mice as described (7, 18) . Then, the BM cells were counted and cultured in 24-well tissue culture plates at 1×10 6 cells per well with DMC7 medium containing GM-CSF as described previously (17) . For short-term (up to 7 days) cultures of BM cells, a half of medium in each well was carefully removed and replenished with new GM-CSF-containing DMC7 medium on every 2 or 3 days. For long-term cultures of BM cells, the extended culture was sustained by removing nonadherent or loosely-attached BM cells periodically, i.e., every 1 or 2 wk, and maintaining only the remaining adherent BM cells in tissue culture plates. Non-adherent or loosely-attached BM cells were discarded or harvested for analysis by mild pipetting and replenished with new GM-CSF-containing DMC7 medium.
Allogeneic MLR
Cell suspensions, prepared by grinding up spleens and lymph nodes from BALB/c mice with frosted glasses and cell strainers (BD Biosciences, San Jose, CA, USA), were incubated with the mixture of biotin-conjugated monoclonal antibodies against CD19, CD49b, and MHC II. After washing with isolation buffer (PBS containing 2% fetal bovine serum and 2 mM EDTA), antibody-reactive cells were removed using biotin-binding magnetic beads (Dynabeads; Thermo Fisher Scientific) according to the manufacturer's instruction. The enriched T cells (1×10 7 cells in 1 ml) were mixed with 1 μl of 0.5 mM CFSE solution and incubated for 10 min at 37°C, followed by quench with DMC7 medium and washed with PBS. Then, for MLR, 5×10 4 of CFSE-labeled T cells were co-cultured with the graded doses of non-adherent or looselyattached cells from the different BM cultures of C57BL/6 mice in 96-well tissue culture plates. After 4 to 5 days, the proliferation of T cells was measured by CFSE dilution detected with FACSVerse™ flowcytometer (BD Biosciences).
Suppressor cell-mediated T cell suppression assay was performed in conjunction with allogeneic MLR. In brief, 1W-BMCs, i.e., C57BL/6 BM cells cultured with GM-CSF for 1 wk, were mixed with graded doses of control syngeneic splenocytes or suppressor cells to be tested, and further subjected to co-incubation with CFSE-labeled allogeneic T cells from BALB/c mice and analysis as described above.
Assay of suppressor cell activity on anti-OVA T cells
Cells in the BM culture were pre-treated with medium containing 100 μg/ml of soluble OVA for 1 h at 37°C. Then, the OVA-laden BMCs were washed twice with cold DMEM and cocultured with anti-OVA OT-I TCR Tg T cells as described below. Splenic OT-I T cells were enriched by excluding CD4 
Stimulation of cells with lipopolysaccharide (LPS)
Cells in the BM cultured for 1 wk or longer than a year were stimulated side by side with LPS (catalog number L2630; Sigma-Aldrich) at 100 μg/ml for 18 h at 37°C. Then, cells were harvested, washed twice with PBS, stained for various surface molecules, and subjected to flow cytometric analysis.
Statistical analysis
Experiments with multiplicate samples were analyzed for statistical comparisons between different groups using unpaired Student's t-test using Prism6 (GraphPad Software, La Jolla, CA, USA). Statistical significance is denoted by the p-values equal or below 0.05, 0.01, and 0.001. Data were plotted for graphs with Prism6.
RESULTS AND DISCUSSION
In our previous study (19) , we found that BM-DCs isolated from 3-or 4-wk old BM cultures were much less efficient to stimulate T cells than BM-DCs from 1-wk old BM culture. To follow up on our previous finding that BM-DCs lose their capacity to induce the proliferation of allogeneic T cells in MLR after the extended culture with GM-CSF (19), we set out to examine the culture of BM cells from C57BL/6 mice for lengthy periods. To sustain and examine the extended culture of BM cells, non-adherent or loosely-attached cells were removed from tissue culture plates every 1 or 2 wk and only the remaining adherent cells were maintained in culture medium containing GM-CSF. Then we discovered that new non-adherent or loosely-attached cells were continually produced from the BM culture of adherent cells, and analyzed those non-adherent or loosely-attached cells periodically for longer than a year. Every 4 wk or so, we compared the capacity to stimulate allogeneic T cells from BALB/c mice in MLR between the 1-wk cultured BM cells and the long-term cultured BM cells. Similarly to our previous study (19) , non-adherent or loosely-attached cells in the 4-wk old BM culture were found less efficient to stimulate allogeneic T cells than those in the 1-wk old BM culture (Fig. 1A) . When cultured for 8 wk, BM cells in the culture (i.e., non-adherent or loosely-attached cells in the BM culture) became almost completely unable to stimulate the proliferation of allogeneic T cells in MLR (Fig. 1B) . The loss of capability to stimulate allogeneic T cells in MLR was continuously observed from BM cells in the long-term culture throughout the extended periods of their culture with GM-CSF (Supplementary Fig. 1 ).
Non-adherent or loosely-attached BM cells in the 1-wk culture with GM-CSF are composed of heterogeneous populations including a large majority of CD11c Fig. 2A) , whereas those cultured for 20 wk or longer became a relatively homogeneous population in terms of expressing surface MHC II (Fig. 2B) .
Although cells from the long-term cultures of BM with GM-CSF were unable to stimulate allogeneic T cells in MLR (Supplementary Fig. 1 ), those cells expressed both MHC I and MHC II on surface throughout the extended culture periods (Figs. 2 and 3) . Then, we examined whether BM cells from the long-term culture possessed the ability to suppress T cell responses. Fig. 4 , cells from the BM cultured for 32 wk or longer were found to effectively suppress the proliferation of allogeneic T cells in MLR stimulated by the 1-wk cultured BM cells. This suppressor activity of the long-term cultured BM cells was maintained throughout our examinations which lasted well over a year (Fig. 4 and Supplementary Fig. 1 ). Then, we further investigated whether those BM cells in the long-term culture exert their suppressor activity in antigen-dependent manner. The long-term cultured BM cells were treated with/without OVA before adding into the co-culture with the OVA-loaded 1-wk cultured BM cells and anti-OVA OT-I TCR transgenic T cells. Only the long-term cultured BM cells laden with OVA were able to suppress the response of OVA-specific OT-I T cells (Fig. 5) .
As shown in
Our results indicate that BM cells cultured with GM-CSF undergo 2 distinct steps of functional change; the BM cells cultured for 8 wk or longer lose immunostimulatory capacity; and those cultured for 32 wk or longer gain immunosuppressive ability. To evaluate whether these changes are due to the altered expression of surface molecules, we compared the levels of various costimulatory and surface molecules between the 1-wk cultured BM cells and the 70-wk cultured BM cells. The expression of CD25, CD40, CD80, CD86, PD-L2, and MHC I were significantly diminished while the expression of PD-L1 was augmented on the surface of the 70-wk cultured BM cells (Fig. 3) . We also tested whether the stimulation with LPS, a TLR4 agonist, could change the function of the long-term cultured BM cells. As shown in Fig. 6 , LPS treatment increased the immunostimulatory activity of the 1-wk cultured BM cells but exhibited no such effect on the long-term cultured BM cells.
It is currently not yet clear that the expressional change of these co-stimulatory molecules during extended culture is responsible for those BM cells to lose immunostimulatory capacity or to gain immunosuppressive ability. The new features acquired by the BM cells in the extended cultures are apparently shared by the typical phenotypes of tolerogenic DCs, including the increased level of PD-L1 and the decreased levels of CD40, CD80, CD86 (22) . Further investigation is needed to define the mechanisms that cause the functional changes of BM cells in the course of the extended culture with GM-CSF. 
